Published by Josh White on 10th June 2020
(Sharecast News) - E-therapeutics has entered a collaboration agreement with Galapagos to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF), and potentially in other fibrotic indications, it announced on Wednesday.
URL: http://www.digitallook.com/dl/news/story/30773901/...